INSIGHTS

Antibody-based drug discovery at the speed of light

 WHITE PAPER

Discovery

The combination of the PentaMice^® platform and single B cell screening with the Berkeley Lights Beacon® Optofluidic system increases speed to market for monoclonal antibody therapeutics.

The Beacon^® system is an innovative package using the technology of light, nanofluidics and refined AI algorithms to identify and orchestrate the movement of single B cells into a grid of NanoPen™ chambers for screening.

Download our white paper for insights on:

• First-to-Human antibody therapeutics
• Immunization — PentaMice® platform for antibody generation
• Single B cell screening with the Beacon® system
• Sequence Identification
• Custom Bioinformatics
• Case Study: Discovery of diverse monoclonal antibodies that bind SARS-CoV-2 Delta and Omicron spike proteins
• Gene-to-Protein Strategies

Fill out the form to download the white paper today!